Click for best price
Drugs for Short Bowel Syndrome Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Drugs for Short Bowel Syndrome, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Short Bowel Syndrome. This report contains market size and forecasts of Drugs for Short Bowel Syndrome in global, including the following market information:
Global Drugs for Short Bowel Syndrome Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Drugs for Short Bowel Syndrome market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
GLP-2 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Drugs for Short Bowel Syndrome include Ardelyx, Emmaus Life Sciences, GLyPharma Therapeutic, Merck, Naia Pharmaceuticals, Nutrinia, OxThera, Sancilio & Company and Takeda, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Drugs for Short Bowel Syndrome companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Short Bowel Syndrome Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Drugs for Short Bowel Syndrome Market Segment Percentages, by Type, 2022 (%)
GLP-2
Growth Hormone
Glutamine
Other
Global Drugs for Short Bowel Syndrome Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Drugs for Short Bowel Syndrome Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Drugs for Short Bowel Syndrome Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Drugs for Short Bowel Syndrome Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs for Short Bowel Syndrome revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Drugs for Short Bowel Syndrome revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ardelyx
Emmaus Life Sciences
GLyPharma Therapeutic
Merck
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio & Company
Takeda
Zealand Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drugs for Short Bowel Syndrome, market overview.
Chapter 2: Global Drugs for Short Bowel Syndrome market size in revenue.
Chapter 3: Detailed analysis of Drugs for Short Bowel Syndrome company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drugs for Short Bowel Syndrome in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Drugs for Short Bowel Syndrome Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Drugs for Short Bowel Syndrome Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Short Bowel Syndrome Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Short Bowel Syndrome Overall Market Size
2.1 Global Drugs for Short Bowel Syndrome Market Size: 2022 VS 2029
2.2 Global Drugs for Short Bowel Syndrome Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drugs for Short Bowel Syndrome Players in Global Market
3.2 Top Global Drugs for Short Bowel Syndrome Companies Ranked by Revenue
3.3 Global Drugs for Short Bowel Syndrome Revenue by Companies
3.4 Top 3 and Top 5 Drugs for Short Bowel Syndrome Companies in Global Market, by Revenue in 2022
3.5 Global Companies Drugs for Short Bowel Syndrome Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs for Short Bowel Syndrome Players in Global Market
3.6.1 List of Global Tier 1 Drugs for Short Bowel Syndrome Companies
3.6.2 List of Global Tier 2 and Tier 3 Drugs for Short Bowel Syndrome Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Drugs for Short Bowel Syndrome Market Size Markets, 2022 & 2029
4.1.2 GLP-2
4.1.3 Growth Hormone
4.1.4 Glutamine
4.1.5 Other
4.2 By Type - Global Drugs for Short Bowel Syndrome Revenue & Forecasts
4.2.1 By Type - Global Drugs for Short Bowel Syndrome Revenue, 2018-2023
4.2.2 By Type - Global Drugs for Short Bowel Syndrome Revenue, 2024-2029
4.2.3 By Type - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drugs for Short Bowel Syndrome Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Drugs for Short Bowel Syndrome Revenue & Forecasts
5.2.1 By Application - Global Drugs for Short Bowel Syndrome Revenue, 2018-2023
5.2.2 By Application - Global Drugs for Short Bowel Syndrome Revenue, 2024-2029
5.2.3 By Application - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Drugs for Short Bowel Syndrome Market Size, 2022 & 2029
6.2 By Region - Global Drugs for Short Bowel Syndrome Revenue & Forecasts
6.2.1 By Region - Global Drugs for Short Bowel Syndrome Revenue, 2018-2023
6.2.2 By Region - Global Drugs for Short Bowel Syndrome Revenue, 2024-2029
6.2.3 By Region - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Drugs for Short Bowel Syndrome Revenue, 2018-2029
6.3.2 US Drugs for Short Bowel Syndrome Market Size, 2018-2029
6.3.3 Canada Drugs for Short Bowel Syndrome Market Size, 2018-2029
6.3.4 Mexico Drugs for Short Bowel Syndrome Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Drugs for Short Bowel Syndrome Revenue, 2018-2029
6.4.2 Germany Drugs for Short Bowel Syndrome Market Size, 2018-2029
6.4.3 France Drugs for Short Bowel Syndrome Market Size, 2018-2029
6.4.4 U.K. Drugs for Short Bowel Syndrome Market Size, 2018-2029
6.4.5 Italy Drugs for Short Bowel Syndrome Market Size, 2018-2029
6.4.6 Russia Drugs for Short Bowel Syndrome Market Size, 2018-2029
6.4.7 Nordic Countries Drugs for Short Bowel Syndrome Market Size, 2018-2029
6.4.8 Benelux Drugs for Short Bowel Syndrome Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Drugs for Short Bowel Syndrome Revenue, 2018-2029
6.5.2 China Drugs for Short Bowel Syndrome Market Size, 2018-2029
6.5.3 Japan Drugs for Short Bowel Syndrome Market Size, 2018-2029
6.5.4 South Korea Drugs for Short Bowel Syndrome Market Size, 2018-2029
6.5.5 Southeast Asia Drugs for Short Bowel Syndrome Market Size, 2018-2029
6.5.6 India Drugs for Short Bowel Syndrome Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Drugs for Short Bowel Syndrome Revenue, 2018-2029
6.6.2 Brazil Drugs for Short Bowel Syndrome Market Size, 2018-2029
6.6.3 Argentina Drugs for Short Bowel Syndrome Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drugs for Short Bowel Syndrome Revenue, 2018-2029
6.7.2 Turkey Drugs for Short Bowel Syndrome Market Size, 2018-2029
6.7.3 Israel Drugs for Short Bowel Syndrome Market Size, 2018-2029
6.7.4 Saudi Arabia Drugs for Short Bowel Syndrome Market Size, 2018-2029
6.7.5 UAE Drugs for Short Bowel Syndrome Market Size, 2018-2029
7 Drugs for Short Bowel Syndrome Companies Profiles
7.1 Ardelyx
7.1.1 Ardelyx Company Summary
7.1.2 Ardelyx Business Overview
7.1.3 Ardelyx Drugs for Short Bowel Syndrome Major Product Offerings
7.1.4 Ardelyx Drugs for Short Bowel Syndrome Revenue in Global Market (2018-2023)
7.1.5 Ardelyx Key News & Latest Developments
7.2 Emmaus Life Sciences
7.2.1 Emmaus Life Sciences Company Summary
7.2.2 Emmaus Life Sciences Business Overview
7.2.3 Emmaus Life Sciences Drugs for Short Bowel Syndrome Major Product Offerings
7.2.4 Emmaus Life Sciences Drugs for Short Bowel Syndrome Revenue in Global Market (2018-2023)
7.2.5 Emmaus Life Sciences Key News & Latest Developments
7.3 GLyPharma Therapeutic
7.3.1 GLyPharma Therapeutic Company Summary
7.3.2 GLyPharma Therapeutic Business Overview
7.3.3 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Major Product Offerings
7.3.4 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Revenue in Global Market (2018-2023)
7.3.5 GLyPharma Therapeutic Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Drugs for Short Bowel Syndrome Major Product Offerings
7.4.4 Merck Drugs for Short Bowel Syndrome Revenue in Global Market (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Naia Pharmaceuticals
7.5.1 Naia Pharmaceuticals Company Summary
7.5.2 Naia Pharmaceuticals Business Overview
7.5.3 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Major Product Offerings
7.5.4 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Revenue in Global Market (2018-2023)
7.5.5 Naia Pharmaceuticals Key News & Latest Developments
7.6 Nutrinia
7.6.1 Nutrinia Company Summary
7.6.2 Nutrinia Business Overview
7.6.3 Nutrinia Drugs for Short Bowel Syndrome Major Product Offerings
7.6.4 Nutrinia Drugs for Short Bowel Syndrome Revenue in Global Market (2018-2023)
7.6.5 Nutrinia Key News & Latest Developments
7.7 OxThera
7.7.1 OxThera Company Summary
7.7.2 OxThera Business Overview
7.7.3 OxThera Drugs for Short Bowel Syndrome Major Product Offerings
7.7.4 OxThera Drugs for Short Bowel Syndrome Revenue in Global Market (2018-2023)
7.7.5 OxThera Key News & Latest Developments
7.8 Sancilio & Company
7.8.1 Sancilio & Company Company Summary
7.8.2 Sancilio & Company Business Overview
7.8.3 Sancilio & Company Drugs for Short Bowel Syndrome Major Product Offerings
7.8.4 Sancilio & Company Drugs for Short Bowel Syndrome Revenue in Global Market (2018-2023)
7.8.5 Sancilio & Company Key News & Latest Developments
7.9 Takeda
7.9.1 Takeda Company Summary
7.9.2 Takeda Business Overview
7.9.3 Takeda Drugs for Short Bowel Syndrome Major Product Offerings
7.9.4 Takeda Drugs for Short Bowel Syndrome Revenue in Global Market (2018-2023)
7.9.5 Takeda Key News & Latest Developments
7.10 Zealand Pharma
7.10.1 Zealand Pharma Company Summary
7.10.2 Zealand Pharma Business Overview
7.10.3 Zealand Pharma Drugs for Short Bowel Syndrome Major Product Offerings
7.10.4 Zealand Pharma Drugs for Short Bowel Syndrome Revenue in Global Market (2018-2023)
7.10.5 Zealand Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Drugs for Short Bowel Syndrome Market Opportunities & Trends in Global Market
Table 2. Drugs for Short Bowel Syndrome Market Drivers in Global Market
Table 3. Drugs for Short Bowel Syndrome Market Restraints in Global Market
Table 4. Key Players of Drugs for Short Bowel Syndrome in Global Market
Table 5. Top Drugs for Short Bowel Syndrome Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Drugs for Short Bowel Syndrome Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Drugs for Short Bowel Syndrome Revenue Share by Companies, 2018-2023
Table 8. Global Companies Drugs for Short Bowel Syndrome Product Type
Table 9. List of Global Tier 1 Drugs for Short Bowel Syndrome Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Short Bowel Syndrome Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Drugs for Short Bowel Syndrome Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Drugs for Short Bowel Syndrome Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Drugs for Short Bowel Syndrome Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Drugs for Short Bowel Syndrome Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Drugs for Short Bowel Syndrome Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Drugs for Short Bowel Syndrome Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2024-2029
Table 30. Ardelyx Company Summary
Table 31. Ardelyx Drugs for Short Bowel Syndrome Product Offerings
Table 32. Ardelyx Drugs for Short Bowel Syndrome Revenue (US$, Mn) & (2018-2023)
Table 33. Ardelyx Key News & Latest Developments
Table 34. Emmaus Life Sciences Company Summary
Table 35. Emmaus Life Sciences Drugs for Short Bowel Syndrome Product Offerings
Table 36. Emmaus Life Sciences Drugs for Short Bowel Syndrome Revenue (US$, Mn) & (2018-2023)
Table 37. Emmaus Life Sciences Key News & Latest Developments
Table 38. GLyPharma Therapeutic Company Summary
Table 39. GLyPharma Therapeutic Drugs for Short Bowel Syndrome Product Offerings
Table 40. GLyPharma Therapeutic Drugs for Short Bowel Syndrome Revenue (US$, Mn) & (2018-2023)
Table 41. GLyPharma Therapeutic Key News & Latest Developments
Table 42. Merck Company Summary
Table 43. Merck Drugs for Short Bowel Syndrome Product Offerings
Table 44. Merck Drugs for Short Bowel Syndrome Revenue (US$, Mn) & (2018-2023)
Table 45. Merck Key News & Latest Developments
Table 46. Naia Pharmaceuticals Company Summary
Table 47. Naia Pharmaceuticals Drugs for Short Bowel Syndrome Product Offerings
Table 48. Naia Pharmaceuticals Drugs for Short Bowel Syndrome Revenue (US$, Mn) & (2018-2023)
Table 49. Naia Pharmaceuticals Key News & Latest Developments
Table 50. Nutrinia Company Summary
Table 51. Nutrinia Drugs for Short Bowel Syndrome Product Offerings
Table 52. Nutrinia Drugs for Short Bowel Syndrome Revenue (US$, Mn) & (2018-2023)
Table 53. Nutrinia Key News & Latest Developments
Table 54. OxThera Company Summary
Table 55. OxThera Drugs for Short Bowel Syndrome Product Offerings
Table 56. OxThera Drugs for Short Bowel Syndrome Revenue (US$, Mn) & (2018-2023)
Table 57. OxThera Key News & Latest Developments
Table 58. Sancilio & Company Company Summary
Table 59. Sancilio & Company Drugs for Short Bowel Syndrome Product Offerings
Table 60. Sancilio & Company Drugs for Short Bowel Syndrome Revenue (US$, Mn) & (2018-2023)
Table 61. Sancilio & Company Key News & Latest Developments
Table 62. Takeda Company Summary
Table 63. Takeda Drugs for Short Bowel Syndrome Product Offerings
Table 64. Takeda Drugs for Short Bowel Syndrome Revenue (US$, Mn) & (2018-2023)
Table 65. Takeda Key News & Latest Developments
Table 66. Zealand Pharma Company Summary
Table 67. Zealand Pharma Drugs for Short Bowel Syndrome Product Offerings
Table 68. Zealand Pharma Drugs for Short Bowel Syndrome Revenue (US$, Mn) & (2018-2023)
Table 69. Zealand Pharma Key News & Latest Developments
List of Figures
Figure 1. Drugs for Short Bowel Syndrome Segment by Type in 2022
Figure 2. Drugs for Short Bowel Syndrome Segment by Application in 2022
Figure 3. Global Drugs for Short Bowel Syndrome Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Drugs for Short Bowel Syndrome Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Drugs for Short Bowel Syndrome Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drugs for Short Bowel Syndrome Revenue in 2022
Figure 8. By Type - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2018-2029
Figure 9. By Application - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2018-2029
Figure 10. By Type - Global Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2018-2029
Figure 12. By Application - Global Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2018-2029
Figure 14. By Region - Global Drugs for Short Bowel Syndrome Revenue Market Share, 2018-2029
Figure 15. By Country - North America Drugs for Short Bowel Syndrome Revenue Market Share, 2018-2029
Figure 16. US Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Drugs for Short Bowel Syndrome Revenue Market Share, 2018-2029
Figure 20. Germany Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2029
Figure 21. France Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Drugs for Short Bowel Syndrome Revenue Market Share, 2018-2029
Figure 28. China Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2029
Figure 32. India Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Drugs for Short Bowel Syndrome Revenue Market Share, 2018-2029
Figure 34. Brazil Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Drugs for Short Bowel Syndrome Revenue Market Share, 2018-2029
Figure 37. Turkey Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Drugs for Short Bowel Syndrome Revenue, (US$, Mn), 2018-2029
Figure 41. Ardelyx Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Emmaus Life Sciences Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. GLyPharma Therapeutic Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Naia Pharmaceuticals Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Nutrinia Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. OxThera Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Sancilio & Company Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Takeda Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Zealand Pharma Drugs for Short Bowel Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
